Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...
Mild to moderate COPD with vs without emphysema is associated with significantly worse HRQOL, but similar lung function decline.
Chronic Pulmonary Aspergillosis is a silent but severe threat to individuals with lung diseases making it important to ...
Higher dietary magnesium intake is associated with a reduced risk of frailty in patients with chronic obstructive pulmonary ...
London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review, data from the MATINEE study ...
Yahoo on MSN11h
Wildfire smoke, poor air quality can have an impact on health — even for people who live far away“For people with any kind of chronic lung disease, such as [chronic obstructive pulmonary disease] COPD or asthma, this can ...
News Medical on MSN7d
Key risk factors influencing mortality rates in chronic pulmonary aspergillosis patientsA systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, ...
Obesity has this year overtaken smoking as Australia's leading risk factor contributing to disease, according to a national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback